Skip to content
10-Q

Quarterly Report

TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.

0001104659-11-022974

← back to feed
Filed
Apr 27, 2011 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2011 · Apr 22, 2011 125.99M sh
Stock Repurchased Q1 2011 · Mar 31, 2011 $2.2M
Stock Repurchased Q1 2011 · Mar 31, 2010 $4.92M
Capex Q1 2011 · Mar 31, 2011 $53.27M
Capex Q1 2011 · Mar 31, 2010 $17.69M
Operating Cash Flow Q1 2011 · Mar 31, 2011 $39.63M
Operating Cash Flow Q1 2011 · Mar 31, 2010 $30.67M
Cash And Equivalents Q1 2011 · Mar 31, 2011 $185.34M
Cash And Equivalents Q1 2011 · Dec 31, 2010 $197.88M
Cash And Equivalents Q1 2011 · Mar 31, 2010 $80.27M
Cash And Equivalents Q1 2011 · Dec 31, 2009 $65.24M
Stockholders Equity Q1 2011 · Mar 31, 2011 $852.32M
Stockholders Equity Q1 2011 · Dec 31, 2010 $794.36M
Current Liabilities Q1 2011 · Mar 31, 2011 $292.05M
Current Liabilities Q1 2011 · Dec 31, 2010 $312.56M
Total Liabilities Q1 2011 · Mar 31, 2011 $929.96M
Total Liabilities Q1 2011 · Dec 31, 2010 $944.09M
Current Assets Q1 2011 · Mar 31, 2011 $1.15B
Current Assets Q1 2011 · Dec 31, 2010 $1.15B
Total Assets Q1 2011 · Mar 31, 2011 $1.78B
Total Assets Q1 2011 · Dec 31, 2010 $1.74B
Eps Diluted Q1 2011 · Mar 31, 2011 $0.43
Eps Diluted Q1 2011 · Mar 31, 2010 $0.35
Eps Basic Q1 2011 · Mar 31, 2011 $0.44
Eps Basic Q1 2011 · Mar 31, 2010 $0.37
Sga Expense Q1 2011 · Mar 31, 2011 $62.72M
Sga Expense Q1 2011 · Mar 31, 2010 $67.62M
Rd Expense Q1 2011 · Mar 31, 2011 $16.53M
Rd Expense Q1 2011 · Mar 31, 2010 $16.27M
Net Income Q1 2011 · Mar 31, 2011 $55.46M
Net Income Q1 2011 · Mar 31, 2010 $45.34M
Operating Income Q1 2011 · Mar 31, 2011 $93.8M
Operating Income Q1 2011 · Mar 31, 2010 $79.72M
Gross Profit Q1 2011 · Mar 31, 2011 $173.04M
Gross Profit Q1 2011 · Mar 31, 2010 $163.61M
Cost Of Revenue Q1 2011 · Mar 31, 2011 $233.62M
Cost Of Revenue Q1 2011 · Mar 31, 2010 $217.35M
Revenue Q1 2011 · Mar 31, 2011 $406.66M
Revenue Q1 2011 · Mar 31, 2010 $380.96M